GLPwatch
Trials (2081)
Page 9 of 35.
- Exenatide (Byetta ®) Regulation of Intestinal and Hepatic Lipoprotein Particle Production in Humans
- A Trial to Evaluate Safety, Feasibility and Efficacy of the ReCET Procedure (EMINENT-2)
- Replication of the LEADER Diabetes Trial in Healthcare Claims
- Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus
- A Study of the Safety and Effectiveness of LY3053102 in Participants With Type 2 Diabetes
- Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin in Subjects With Type 2 Diabetes (SUSTAIN - CHINA MRCT)
- Investigation of the Effect of Upper Gastrointestinal Disease on the Pharmacokinetics of Oral Semaglutide in Subjects With Type 2 Diabetes.
- Effect of Dulaglutide on Glycemic Variability in Patients With Type 2 Diabetes
- A Study in Chinese People With Overweight or Obesity to Test How Different Doses of Survodutide Are Taken up in the Body
- Effect of Liraglutide on Heart Frequency in Healthy Volunteers
- The Effect of Exenatide on Weight and Hunger in Obese, Healthy Women
- Semaglutide for Post-Smoking Cessation Weight Management
- Remission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IGlarLixi
- A Research Study to Compare Blood Levels of Cagrilintide and Semaglutide After Combined Versus Separate Injections in People With Overweight or Obesity
- Effect of Exenatide on Cortisol Secretion
- Research Study to Investigate How Well Semaglutide Works Compared to Liraglutide in People Living With Overweight or Obesity
- Semaglutide (SEMA) for Alcohol Use Disorder (AUD) After Metabolic and Bariatric Surgery (MBS)
- A Research Study on How Well Semaglutide Works in Adolescents With Overweight or Obesity
- A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Israel, as Part of Local Clinical Practice
- Efficacy of Oral Semaglutide in Overweight or Obesity
- Influence of Liraglutide, a GLP-1 Receptor Agonist, on Brown Adipose Tissue (BAT) Activity in Humans
- Efficacy Study of Glucagonlike Peptide-1 to Treat Reperfusion Injury
- Impact of Exenatide on Sleep Duration
- A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral Formulation IV
- Effect of Liraglutide on Neural Responses to High Fructose Corn Syrup in Individuals With Obesity.
- Liraglutide as Add on Therapy on Metformin in Women With Polycystic Ovary Syndrome
- How Glargine Insulin, Oral Diabetes Medications and Exenatide May Improve Blood Sugar Control and Weight Gain in Type 2 Diabetics
- A Study of Tirzepatide (LY3298176) Versus Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine With or Without Metformin
- A Study of Tirzepatide Administered by Two Different Devices in Healthy Participants
- A Study of Tirzepatide (LY3298176) in Chinese Participants Without Type 2 Diabetes Who Have Obesity or Overweight (SURMOUNT-CN)
- A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
- A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain
- A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
- Measurement of Alanine Aminotransaminase (ALT) Following Initiation of Antidiabetic Agents in Patients With Type 2 Diabetes in a Real-world Clinical Setting: a Retrospective Cohort Study
- A Research Study to Look Into the Long-term Effect on Weight Loss of CagriSema in People With Obesity
- Exenatide Inpatient Trial: A Randomized Controlled Pilot Trial on the Safety and Efficacy of Exenatide (Byetta®) Therapy for the Inpatient Management of Patients With Type 2 Diabetes
- People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists
- A Phase 1 Study to Assess the Safety of NLY01 in Healthy Subjects
- Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors
- Addition Of Exenatide To Insulin Glargine In Type 2 Diabetes Mellitus
- A Study of LY3532226 in Participants With Type 2 Diabetes Mellitus
- A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both
- A Study of LY3325656 in Healthy Participants and Participants With Type 2 Diabetes
- A Research Study Looking at the Comparability (Bioequivalence) of Two Forms of Semaglutide in Two Different Pen-injectors in People With Overweight or Obesity
- Effect of GLP1 Receptor Agonist on Brain Insulin Responsiveness
- Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
- To Predict Weight Loss Response to Liraglutide (Saxenda®), From fMRI-based Determination of Food Cue Reactivity
- Semaglutide in Women With Polycystic Ovary Syndrome and Obesity
- Does the Hematopoietic Stem Cell Govern Residual Inflammatory Cardiovascular Risk in Type 2 Diabetes
- Exenatide Treatment in Parkinson's Disease
- Exenatide in Extreme Pediatric Obesity
- A 12 Month Site Randomized Trial in Adults With Type 2 Diabetes Mellitus and History of Cardiovascular Disease
- Trial for People With Established Type 2 Diabetes During Ramadan
- A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Mexico, as Part of Local Clinical Practice
- The Impact of Lixisenatide on Postprandial Glucose Tolerance in Pancreatectomised Subjects
- Impact of Semaglutide on CD34+ EPC and Fat Derived MSC
- Does a GLP-1 Receptor Agonist Change Glucose Tolerance in Antipsychotic-treated Patients?
- In Market Utilisation of Liraglutide Used for Weight Management in the UK: a Study in the CPRD Primary Care Database
- Assessment of Pancreatic Beta Cell Mass and Function by Positron Emission Tomography Imaging in Human Diabetes Mellitus
- Efficacy and Safety of Exenatide in the Treatment of Hypothalamic Obesity After Craniopharyngioma Therapy